Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Booking Procedure:
- Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You can make the payment to the technician at the time of collection
- Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
- Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.
Frequently Asked Questions (FAQ's):
What does the Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel include at Metropolis Healthcare?
It analyzes both mitochondrial and nuclear genes associated with energy metabolism using high-accuracy NGS technology.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences targeted regions to detect pathogenic variants linked to mitochondrial encephalopathies.
Who should consider taking this test at Metropolis Healthcare?
Individuals with developmental regression, seizures, metabolic acidosis, or MRI features suggestive of mitochondrial disease may benefit from this panel.
What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is used for high-quality DNA extraction and next-generation sequencing.
How long does Metropolis Healthcare take to provide results?
Results are shared within a typical genetic testing timeline after detailed sequencing and expert interpretation.
Why choose Metropolis Healthcare for mitochondrial disorder testing?
Metropolis Healthcare offers comprehensive gene coverage, precise NGS-based mutation detection, and clinically actionable insights.
Does Metropolis Healthcare provide post-test guidance?
Yes, the report includes expert genetic interpretation to support clinical management and family risk assessment.
Is this test suitable for children at Metropolis Healthcare?
Yes, the panel is appropriate for infants, children, and adults with suspected mitochondrial encephalopathies